ALPHINA Trademark

Trademark Overview

On Monday, March 28, 2022, a trademark application was filed for ALPHINA with the United States Patent and Trademark Office. The USPTO has given the ALPHINA trademark a serial number of 97333551. The federal status of this trademark filing is THIRD EXTENSION - GRANTED as of Monday, October 7, 2024. This trademark is owned by Alphina Therapeutics, Inc.. The ALPHINA trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Medical and scientific research in the field of cancer treatment; Pharmaceutical research and development; Research and development in the field of cancer treatment
alphina

General Information

Serial Number97333551
Word MarkALPHINA
Filing DateMonday, March 28, 2022
Status732 - THIRD EXTENSION - GRANTED
Status DateMonday, October 7, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 14, 2023

Trademark Statements

Goods and ServicesMedical and scientific research in the field of cancer treatment; Pharmaceutical research and development; Research and development in the field of cancer treatment

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, April 1, 2022
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAlphina Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew Haven, CT 06510
Party NameAlphina Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressWestport, CT 06880

Trademark Events

Event DateEvent Description
Thursday, January 12, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, March 31, 2022NEW APPLICATION ENTERED
Friday, April 1, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, January 11, 2023ASSIGNED TO EXAMINER
Wednesday, January 25, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, February 14, 2023PUBLISHED FOR OPPOSITION
Tuesday, February 14, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 11, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, September 26, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, September 26, 2023SOU EXTENSION 1 FILED
Tuesday, September 26, 2023SOU EXTENSION 1 GRANTED
Thursday, September 28, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, April 2, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, April 3, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, September 19, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, September 19, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, September 19, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, April 2, 2024SOU EXTENSION 2 GRANTED
Tuesday, April 2, 2024SOU EXTENSION 2 FILED
Thursday, September 19, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, September 19, 2024TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Monday, October 7, 2024SOU TEAS EXTENSION RECEIVED
Monday, October 7, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, October 7, 2024SOU EXTENSION 3 FILED
Monday, October 7, 2024SOU EXTENSION 3 GRANTED
Tuesday, October 15, 2024TEAS STATEMENT OF USE RECEIVED
Thursday, September 19, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED

Related Keywords

alphina research treatment development cancer field scientific pharmaceutical medical